Clinton and Cuomo Applaud the Work of CRI Scientists at Annual Awards Dinner September 23, 2015December 14, 2022 Matthew Tontonoz
In a First, FDA Approves Immunotherapy Combination for Advanced Melanoma October 1, 2015December 14, 2022 Matthew Tontonoz
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
What Is an Oncogene? Immunologists Rethink a Fundamental Cancer Concept October 21, 2015December 14, 2022 Matthew Tontonoz
FDA Approves First in a New Class of Immunotherapies October 27, 2015December 14, 2022 Matthew Tontonoz
